Inmolecule Nanotech (FRA:DC0) Marketable Securities: €0.00 Mil (As of Dec. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:DC0 Inmolecule Nanotech SA FRA:DC0
6 GF Score
Price €3.84
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Marketable Securities?

Inmolecule Nanotech FRA:DC0 6 Marketable Securities is €0.00 Mil as of Dec. 2024. GuruFocus rates FRA:DC0 with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Inmolecule Nanotech's Marketable Securities for the quarter that ended in Dec. 2024 was €0.00 Mil.

Inmolecule Nanotech  (FRA:DC0) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Inmolecule Nanotech Marketable Securities Related Terms

Inmolecule Nanotech Marketable Securities Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Marketable Securities Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Marketable Securities
0.00 0.00

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Marketable Securities 0.00 0.00
FRA:DC0
6GF Score
Inmolecule Nanotech SA FRA:DC0
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.00 Mil mean?
Inmolecule Nanotech (FRA:DC0) has a Marketable Securities of €0.00 Mil as of Dec. 2024. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Marketable Securities too high?
Inmolecule Nanotech's current Marketable Securities is €0.00 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Marketable Securities compare to VRTX and REGN?
Inmolecule Nanotech's Marketable Securities of €0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Biotechnology company?
A good Marketable Securities depends on the Biotechnology industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Marketable Securities is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (FRA:DC0) has a current Marketable Securities of €0.00 Mil. The current Marketable Securities is €0.00 Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Inmolecule Nanotech (FRA:DC0), the current Marketable Securities is €0.00 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Other Exchanges MLINA:France
Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for FRA:DC0

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.84
Price